The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Electronic cigarettes for smoking cessation and reduction
Open accessAbstract
BACKGROUND: Electronic cigarettes (ECs) are electronic devices that heat a liquid - usually comprising propylene glycol and glycerol, with or without nicotine and flavours, stored in disposable or refillable cartridges or a reservoir - into an aerosol for inhalation. Since ECs appeared on the market in 2006 there has been a steady growth in sales. Smokers report using ECs to reduce risks of smoking, but some healthcare organisations have been reluctant to encourage smokers to switch to ECs, citing lack of evidence of efficacy and safety. Smokers, healthcare providers and regulators are interested to know if these devices can reduce the harms associated with smoking. In particular, healthcare providers have an urgent need to know what advice they should give to smokers enquiring about ECs. OBJECTIVES: To examine the efficacy of ECs in helping people who smoke to achieve long-term abstinence; to examine the efficacy of ECs in helping people reduce cigarette consumption by at least 50% of baseline levels; and to assess the occurrence of adverse events associated with EC use. SEARCH METHODS: We searched the Cochrane Tobacco Addiction Groups Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and two other databases for relevant records from 2004 to July 2014, together with reference checking and contact with study authors. SELECTION CRITERIA: We included randomized controlled trials (RCTs) in which current smokers (motivated or unmotivated to quit) were randomized to EC or a control condition, and which measured abstinence rates or changes in cigarette consumption at six months or longer. As the field of EC research is new, we also included cohort follow-up studies with at least six months follow-up. We included randomized cross-over trials and cohort follow-up studies that included at least one week of EC use for assessment of adverse events. DATA COLLECTION AND ANALYSIS: One review author extracted data from the included studies and another checked them. Our main outcome measure was abstinence from smoking after at least six months follow-up, and we used the most rigorous definition available (continuous, biochemically validated, longest follow-up). For reduction we used a dichotomous approach (no change/reduction < 50% versus reduction by 50% or more of baseline cigarette consumption). We used a fixed-effect Mantel-Haenszel model to calculate the risk ratio (RR) with a 95% confidence interval (CI) for each study, and where appropriate we pooled data from these studies in meta-analyses. MAIN RESULTS: Our search identified almost 600 records, from which we include 29 representing 13 completed studies (two RCTs, 11 cohort). We identified nine ongoing trials. Two RCTs compared EC with placebo (non-nicotine) EC, with a combined sample size of 662 participants. One trial included minimal telephone support and one recruited smokers not intending to quit, and both used early EC models with low nicotine content. We judged the RCTs to be at low risk of bias, but under the GRADE system the overall quality of the evidence for our outcomes was rated 'low' or 'very low' because of imprecision due to the small number of trials. A 'low' grade means that further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. A 'very low' grade means we are very uncertain about the estimate. Participants using an EC were more likely to have abstained from smoking for at least six months compared with participants using placebo EC (RR 2.29, 95% CI 1.05 to 4.96; placebo 4% versus EC 9%; 2 studies; GRADE: low). The one study that compared EC to nicotine patch found no significant difference in six-month abstinence rates, but the confidence intervals do not rule out a clinically important difference (RR 1.26, 95% CI: 0.68 to 2.34; GRADE: very low). A higher number of people were able to reduce cigarette consumption by at least half with ECs compared with placebo ECs (RR 1.31, 95% CI 1.02 to 1.68, 2 studies; placebo: 27% versus EC: 36%; GRADE: low) and compared with patch (RR 1.41, 95% CI 1.20 to 1.67, 1 study; patch: 44% versus EC: 61%; GRADE: very low). Unlike smoking cessation outcomes, reduction results were not biochemically verified.None of the RCTs or cohort studies reported any serious adverse events (SAEs) that were considered to be plausibly related to EC use. One RCT provided data on the proportion of participants experiencing any adverse events. Although the proportion of participants in the study arms experiencing adverse events was similar, the confidence intervals are wide (ECs vs placebo EC RR 0.97, 95% CI 0.71 to 1.34; ECs vs patch RR 0.99, 95% CI 0.81 to 1.22). The other RCT reported no statistically significant difference in the frequency of AEs at three- or 12-month follow-up between the EC and placebo EC groups, and showed that in all groups the frequency of AEs (with the exception of throat irrita
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Nicotine replacement therapy for smoking cessation
Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,464
Self-citationShape of the relapse curve and long-term abstinence among untreated smokers
Hughes, J. R., Keely, J., & Naud, S. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00540.x · Cited by 1,414
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Outcome criteria in smoking cessation trials: proposal for a common standard
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005) · Addiction · doi:10.1111/j.1360-0443.2004.00995.x · Cited by 1,285
E-Cigarettes: A Scientific Review
Grana, R., Benowitz, N., & Glantz, S. A. (2014) · Circulation · doi:10.1161/circulationaha.114.007667 · Cited by 1,194
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Electronic cigarettes for smoking cessation: a randomised controlled trial.
Bullen, C., Howe, C., Laugesen, M., McRobbie, H., Parag, V., Williman, J., & Walker, N. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61842-5 · Cited by 1,094
Self-citationIndividual behavioural counselling for smoking cessation
Lancaster, T., & Stead, L. F. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001292.pub2 · Cited by 1,015
Nicotine receptor partial agonists for smoking cessation
Hey, K., Lancaster, T., & Bala, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103 · Cited by 861
Cited by
Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,334
Electronic cigarettes for smoking cessation
Hartmann-Boyce, J., McRobbie, H., Bullen, C., Begh, R., Stead, L. F., & Hajek, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub3 · Cited by 1,002
Self-citationKalkhoran, S., & Glantz, S. A. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00521-4 · Cited by 895
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00214-2017 · Cited by 881
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · Respirology · doi:10.1111/resp.13012 · Cited by 681
Psychosocial interventions for supporting women to stop smoking in pregnancy
Chamberlain, C., O'Mara-Eves, A., Porter, J., Coleman, T., Perlen, S. M., Thomas, J., & McKenzie, J. E. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001055.pub5 · Cited by 650
E-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications
Glantz, S. A., & Bareham, D. W. (2018) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-040617-013757 · Cited by 521
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.05.037 · Cited by 486
Overview of Electronic Nicotine Delivery Systems: A Systematic Review
Glasser, A. M., Collins, L., Pearson, J. L., Abudayyeh, H., Niaura, R. S., Abrams, D. B., & Villanti, A. C. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.10.036 · Cited by 473
Electronic cigarettes: what are they and what do they do?
Breland, A., Soule, E., Lopez, A., Ramôa, C., El‐Hellani, A., & Eissenberg, T. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12977 · Cited by 341
Electronic cigarettes for smoking cessation
Hartmann-Boyce, J., Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub7 · Cited by 320
Self-citationElectronic cigarettes for smoking cessation
Hartmann-Boyce, J., McRobbie, H., Butler, A. R., Lindson, N., Bullen, C., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub5 · Cited by 312
Self-citationVogelmeier, C. F., Criner, G. J., Martínez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2017.02.001 · Cited by 309
Cardiovascular effects of electronic cigarettes
Benowitz, N. L., & Fraiman, J. B. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.36 · Cited by 309
Abrams, D. B., Glasser, A. M., Pearson, J. L., Villanti, A. C., Collins, L. K., & Niaura, R. S. (2018) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-040617-013849 · Cited by 298
Electronic Cigarettes for Smoking Cessation: A Systematic Review
Malas, M., van der Tempel, J., Schwartz, R., Minichiello, A., Lightfoot, C., Noormohamed, A., Andrews, J., Zawertailo, L., & Ferrence, R. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw119 · Cited by 289
The health effects of electronic cigarettes
Dinakar, C., & O’Connor, G. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1502466 · Cited by 284
Patnode, C. D., Henderson, J. T., Thompson, J. H., Senger, C. A., Fortmann, S. P., & Whitlock, E. P. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0171 · Cited by 238
Electronic cigarettes for smoking cessation
Hartmann-Boyce, J., McRobbie, H., Lindson, N., Bullen, C., Begh, R., Theodoulou, A., Notley, C., Rigotti, N., Turner, T., Butler, A., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010216.pub · Cited by 179
Self-citationF. Piepoli, M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9583-6 · Cited by 162
Nicotine Replacement Therapy : An Overview
Wadgave, U., & L., N. (2016) · International Journal of Health Sciences · doi:10.12816/0048737 · Cited by 141
A naturalistic, randomized pilot trial of e-cigarettes: uptake, exposure, and behavioral effects.
Carpenter, M. J., Heckman, B. W., Wahlquist, A. E., Wagener, T. L., Goniewicz, M. L., Gray, K. M., Froeliger, B., & Cummings, K. M. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0460 · Cited by 93
Conner, M., Grogan, S., West, R., Simms-Ellis, R., Scholtens, K., Sykes-Muskett, B., Cowap, L., Lawton, R., Armitage, C. J., Meads, D., et al. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000387 · Cited by 76
Masiero, M., Lucchiari, C., Mazzocco, K., Veronesi, G., Maisonneuve, P., Jemos, C., Salè, E. O., Spina, S., Bertolotti, R., & Pravettoni, G. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty047 · Cited by 65
Chen, H., Li, G., Chan, Y. L., Nguyen, T., van Reyk, D., Saad, S., & Oliver, B. G. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.07.001 · Cited by 56
Past, present and future of living systematic review: a bibliometrics analysis
Zheng, Q., Xu, J., Gao, Y., Liu, M., Cheng, L., Xiong, L., Cheng, J., Yuan, M., OuYang, G., Huang, H., et al. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-009378 · Cited by 51
Smoking cessation strategies for patients with asthma: improving patient outcomes
Perret, J., Boneveski, B., McDonald, C., & Abramson, M. (2016) · Journal of Asthma and Allergy · doi:10.2147/jaa.s85615 · Cited by 44
Regan, A. K., & Pereira, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-92930-5 · Cited by 43
Hofmann, P., Benden, C., Kohler, M., & Schuurmans, M. M. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.07.16 · Cited by 37
“Dual consumption of tobacco cigarettes and e-cigarettes is a common finding, thus, making e-cigarettes a questionable smoking cessation aid for transplant recipients, who should achieve immediate and complete tobacco abstinence (62,63).”
BackgroundVolesky, K. D., Maki, A., Scherf, C., Watson, L. M., Cassol, E., & Villeneuve, P. J. (2016) · Health Promotion and Chronic Disease Prevention in Canada · doi:10.24095/hpcdp.36.7.02 · Cited by 36
Considerations related to vaping as a possible gateway into cigarette smoking: An analytical review
Lee, P. N., Coombs, K. J., & Afolalu, E. F. (2018) · F1000Research · doi:10.12688/f1000research.16928.1 · Cited by 14
Santiago-Torres, M., Mull, K. E., Sullivan, B. M., & Bricker, J. B. (2024) · Substance Use & Misuse · doi:10.1080/10826084.2023.2293732 · Cited by 5
Metadata
- Authors
- McRobbie, H., Bullen, C., Hartmann-Boyce, J., & Hajek, P.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2014-12-17
- Issue
- 12
- Pages
- CD010216-CD010216
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W1794449622
- Cited by
- 551
- References
- 113
- Type
- reference entry
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.